FTRE

FORTREA HLDGS INC

FTRE·34965K107·US·Common Stock·Healthcare - Biotechnology-13D/G

FTRE (FORTREA HLDGS INC) is held by 144 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($142.7M), GOLDMAN SACHS GROUP INC ($76.3M), STATE STREET CORP ($38.7M). Net institutional sentiment: Mixed.

144
Holders
(13 Elite)
$730.9M
Total Value
60% (146)
Consensus
87 buying - 59 selling
13F: Insider & Congress:
FTRE

Smart Money Verdict

View all
Held by 144 funds
13 elite

Who's Trading

InsiderTAThakral AnshulSell $1.0MAug 6, 2026
InsiderTAThakral AnshulSell $1.0MAug 6, 2026
InsiderTAThakral AnshulSell $941KAug 5, 2026
InsiderTAThakral AnshulSell $972KAug 5, 2026
InsiderSMSANDERS MACHELLESell $175KAug 3, 2026
InsiderMAMorais Mark A.Sell $79KJun 10, 2026
InsiderMGMcconnell Jill G.Sell $75KJun 2, 2026
ActivistVAVanguard Capital Management5.0%Apr 29, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
CongressJames French HillJames French HillSale $1,001 - $15,000Jun 23, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
15.2M(+2.6%)$142.7M0.0%-2.74%
31
Decreased
8.1M(-2.1%)$76.3M0.0%+189.88%
0
Decreased
4.1M(-0.0%)$38.7M0.0%-31.99%
0
New
4M$38M0.0%+68.80%
40
New
3.7M$34.8M0.0%+68.80%
40
Increased
3.3M(+10.4%)$30.5M0.0%+158.57%
32
Decreased
3.2M(-0.3%)$30.2M0.0%+38.10%
0
Increased
2.6M(+0.5%)$24.2M0.0%+129.43%
29
Increased
2.4M(+3.8%)$22.3M0.0%-14.52%
30
Decreased
2.3M(-6.9%)$21.6M0.0%+63.10%
0
New
1.8M$17.2M0.0%+68.80%
39
Increased
1.8M(+31.9%)$17M0.1%+15.25%
36
Increased
1.6M(+241.0%)$14.9M0.0%+32.92%
45
Increased
1.4M(+81.4%)$13.5M0.0%+68.84%
43
Increased
1.3M(+163.8%)$12.2M0.0%+2.53%
45
Decreased
1.2M(-52.9%)$11.7M0.0%-4.02%
0
Decreased
1.1M(-48.9%)$10.1M0.0%+84.85%
0
Increased
1M(+3.8%)$9.4M0.0%-2.32%
29
Increased
1M(+82.2%)$9M0.0%+64.01%
42
Increased
855,510(+49.5%)$8.1M0.0%+55.81%
38

Showing 1-20 of 160

1 / 8
FTREFTREFORTREA HLDGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used